20 September 1996
Extracellular Matrix Proteins: Bystanders Or Active Participants In The Allograft Rejection Cascade?
Ann Transplant 1996; 1(3): 14-18 :: ID: 496663
Abstract
The role extracellularmatrix (ECM)proteins mayplayin the host immune cascade triggered by organ transplantation is largelyunknown.We have employed
well-defined rat cardiac allograft model to test the hypothesis that the expression of ECM componentS, such as fibronectin (FN) or laminin (LN), representS an integral part of the host rejection response in transplant recipientS. Indeed, treatment of ratS with anti-LN Ab profoundly affected lymphocyte recirculation pathways, and selectively decreased deposition of alloreactive lymphocytes at the graft site and in host peripheral lymph nodes. Moreover, cardiac rejection was accompanied by markedly increased intragraft expression of both LN and FN. The infiltrating mononuclear cells, however, accumulated selectively'in FN- rather than LN-rich cardiac areas. We also observed distinct temporal expression and spatial distribution patterns of FN variantS in rat cardiac allograftS and isograftS, The local synthesis of FN, in both allograftS and isografts was increased as early as at 3 h post-transplant. The expression of FN in cardiac allografts but not in isografts, remained high during later intervals to the point of ultimate rejection. The newly synthesized FNs derived from graft infiltrating macrophages and arterioles, and included EIlIA+, EIIIB+, and CS-I + splicing variants. The EIIIAwas preferentially enriched in the earlier, whereas EIIIBand CS-I were selectively enhanced in the later, rejection phases. Finally, treatment of rat recipientS with synthetic FN-CS-I peptides prevented the incidence of early (acute) and late (chronic) rejection, supporting the notion that distinct FNs may playa fundamental role in the host immune cascade triggered by organ transplantation, These data offer potential novel sites for intervention in the control of transplant rejection, and contribute to the development of refined therapeutic strategies based upon new concepts of host immunosuppression.
Keywords: Extracellular Matrix, Transplantation, Allograft rejection, Integrins, fibronectin peptides, fibronectin
In Press
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
18 Mar 2024 : Original article
Does Antibiotic Use Increase the Risk of Post-Transplantation Diabetes Mellitus? A Retrospective Study of R...Ann Transplant In Press; DOI: 10.12659/AOT.943282
20 Mar 2024 : Original article
Transplant Nephrectomy: A Comparative Study of Timing and Techniques in a Single InstitutionAnn Transplant In Press; DOI: 10.12659/AOT.942252
28 Mar 2024 : Original article
Association Between FEV₁ Decline Rate and Mortality in Long-Term Follow-Up of a 21-Patient Pilot Clinical T...Ann Transplant In Press; DOI: 10.12659/AOT.942823
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860